CVS Health’s stock up after earnings beat, but company lowers full-year EPS guidance

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 21 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 97%

Nigeria News News

Nigeria Nigeria Latest News,Nigeria Nigeria Headlines

Ciara Linnane is MarketWatch's investing- and corporate-news editor. She is based in New York.

CVS Health Corp.’s stock CVS, +1.47% was up 0.8% premarket Wednesday, after the drug store chain posted stronger-than-expected third-quarter earnings, shrugging off lower profit guidance for the full year. The company had net income of $2.265 billion, or $1.75 a share, for the quarter, after a loss of $3.399 billion, or $2.59 a share, in the year-earlier period. Adjusted per-share earnings came to $2.

21, ahead of the $2.13 FactSet consensus. Revenue rose to $89.764 billion from $81.159 billion, also ahead of the $88.287 billion FactSet consensus. The company is now expecting full-year EPS to range from $6.37 to $6.61, down from prior guidance of $6.53 to $6.75. Adjusted EPS is still expected at $8.50 to $8.70. The stock has fallen 26% in the year to date, while the S&P 500 SPX, +0.65% has gained 9%.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in NG

Nigeria Nigeria Latest News, Nigeria Nigeria Headlines